Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 9 de 9
1.
Cephalalgia ; 41(11-12): 1272-1275, 2021 10.
Article En | MEDLINE | ID: mdl-34082583

BACKGROUND: One of the advantages of CGRP monoclonal antibodies is their excellent safety and tolerability. However, postmarketing surveillance, is essential to detect potential rare emergent adverse events. OBJECTIVES: To report two patients who developed restless legs syndrome symptoms after treatment with CGRP antibodies. METHODS AND RESULTS: Two women with chronic refractory migraine, with no significant medical antecedents, developed typical restless legs syndrome symptoms 1.5 and 4 months after starting erenumab 140 mg, respectively. In case 1 symptoms resolved when erenumab was stopped for two months but reappeared on galcanezumab. In both patients migraine attacks had dramatically decreased and no iron deficiency was found. CONCLUSIONS: Even though caution is needed before establishing a causal relationship, these cases suggest that restless legs-like symptoms might be an emergent adverse event of CGRP antibodies, regardless of the mechanism of action. We propose that plastic changes in CGRP sensory fibers, which are very abundant in legs, induced by CGRP monoclonal antibodies could be the reason for restless legs syndrome development.


Migraine Disorders , Restless Legs Syndrome , Antibodies, Monoclonal/adverse effects , Calcitonin Gene-Related Peptide , Calcitonin Gene-Related Peptide Receptor Antagonists/therapeutic use , Female , Humans , Migraine Disorders/chemically induced , Migraine Disorders/drug therapy , Restless Legs Syndrome/chemically induced , Restless Legs Syndrome/diagnosis , Restless Legs Syndrome/drug therapy
2.
J Alzheimers Dis ; 79(2): 863-874, 2021.
Article En | MEDLINE | ID: mdl-33361588

BACKGROUND: Major surgery has been associated with perioperative neurocognitive disorders (PND), but the contributing factors and long-term prognosis are uncertain. We hypothesize that preclinical Alzheimer's disease (AD) might predispose to cognitive deterioration after surgery. OBJECTIVE: To analyze the effect of amyloid-ß on the cognitive trajectory after orthopedic surgery in a sample of non-demented subjects. METHODS: Non-demented individuals older than 65 years that were on the waiting list for orthopedic surgery with spinal anesthesia underwent a neuropsychological assessment before and after surgery. During surgery, cerebrospinal fluid samples were obtained to determine AD biomarkers. RESULTS: Cumulative incidence of PND was 55.2%during a mean follow-up of nine months. The most affected cognitive domains were executive function and constructional praxis. The presence of abnormal levels of amyloid-ß was associated to a postoperative impairment in verbal and visual memory tests. According to their AD biomarker profile, participants were categorized as either Amyloid Positive (A+) or Amyloid Negative (A-). The incidence of PND did not differ between both groups. The A- group showed a tendency similar to the global sample, worsening in executive function tests and improving on memory scales due to practice effects. In contrast, the A + group showed a notable worsening on memory performance. CONCLUSION: Our findings support the hypothesis that surgery may promote or accelerate memory decline in cognitively asymptomatic subjects with brain amyloid-ß deposits.


Memory Disorders/etiology , Orthopedic Procedures/adverse effects , Plaque, Amyloid/complications , Aged , Aged, 80 and over , Amyloid beta-Peptides/metabolism , Brain/pathology , Disease Progression , Female , Humans , Male , Neuropsychological Tests , Plaque, Amyloid/pathology
3.
Cortex ; 128: 162-173, 2020 07.
Article En | MEDLINE | ID: mdl-32361266

OBJECTIVE: The structure of the semantic network is constructed and organized during childhood development. Previous publications have hypothesized that neurodegenerative diseases would lead to a disruption of this network reversing the steps acquired in childhood. Semantic Dementia (SD) is a subtype of frontotemporal lobe degeneration in which the main symptom is a specific loss of semantic memory. We aimed to describe the sequential acquisition of concepts in 3-8 years old children evaluated through the production of drawings and, in parallel, their progressive loss in SD patients. METHODS: 104 children between 40 and 96 months categorized into tertiles according to their age, 21 SD patients categorized into tertiles according to their score on a category fluency task and 34 healthy volunteers were asked to draw 12 items with, a priori, different age of acquisition and familiarity, belonging to four different semantic categories. We employed the drawings of the healthy volunteers to build a scoring scheme. We considered that a concept was acquired in children when 50% or more of its features were present in their drawings, and it was lost in patients when more than 50% were missing. RESULTS: Those concepts which the children were able to acquire earlier, according to our scoring scheme, tended to remain in patients with more advanced SD. While the items that children acquired later, were, in general, those that the SD patients lost at earlier disease stages. CONCLUSION: The patterns of concept acquisition in children were the mirror image of the loss in patients with SD. Our study supports the hypothesis that the sequence of concept acquisition in childhood is reversed in SD patients.


Frontotemporal Dementia , Frontotemporal Lobar Degeneration , Adult , Animals , Child , Child, Preschool , Humans , Memory , Neuropsychological Tests , Semantics , Snakes , Young Adult
4.
J Alzheimers Dis ; 72(4): 1129-1144, 2019.
Article En | MEDLINE | ID: mdl-31683488

BACKGROUND: Semantic dementia (SD) is a subtype of frontotemporal dementia (FTD) characterized by semantic memory loss and preserved abilities of other cognitive functions. The clinical manifestations of SD require a differential diagnosis with Alzheimer's disease (AD), especially those with early onset, and behavioral variant FTD (bvFTD). OBJECTIVE: The present study aimed to compare cognitive performances and neuropsychiatric symptoms in a population of AD, bvFTD, and left and right SD defined with the support of molecular imaging (amyloid and 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography) and assessed the accuracy of different neuropsychological markers in distinguishing these neurodegenerative diseases. METHODS: Eighty-seven participants (32 AD, 20 bvFTD, and 35 SD (17 Left-SD and 18 Right-SD) completed a comprehensive neuropsychological battery that included memory, language, attention and executive functions, visuospatial function, visuoconstructional skills, and tasks designed specifically to evaluate prosopagnosia and facial emotions recognition. The Neuropsychiatric Inventory was administered to assess neuropsychiatric symptoms. RESULTS: An episodic memory test that included semantic cues, a visuospatial test (both impaired in AD), a naming test and a prosopagnosia task (both impaired in SD) were the four most valuable cognitive metrics for the differential diagnosis between groups. Several behavioral abnormalities were differentially present, of which aggression, self-care (both more frequent in bvFTD), and eating habits, specifically overeating and altered dietary preference (more frequent in SD), were the most valuable in group discrimination. CONCLUSION: Our study highlights the value of a comprehensive neuropsychological and neuropsychiatric evaluation for the differential diagnosis between FTD syndromes and AD.


Alzheimer Disease/diagnosis , Brain/diagnostic imaging , Cognition/physiology , Dementia/diagnosis , Frontotemporal Dementia/diagnosis , Memory/physiology , Aged , Aged, 80 and over , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/psychology , Dementia/diagnostic imaging , Dementia/psychology , Diagnosis, Differential , Executive Function/physiology , Female , Frontotemporal Dementia/diagnostic imaging , Frontotemporal Dementia/psychology , Humans , Male , Middle Aged , Neuropsychological Tests , Positron-Emission Tomography
5.
J Alzheimers Dis ; 72(1): 151-160, 2019.
Article En | MEDLINE | ID: mdl-31561372

BACKGROUND: Semantic dementia (SD) is a subtype of frontotemporal lobe degeneration characterized by semantic loss, with other cognitive functions initially preserved. SD requires differential diagnosis with Alzheimer's disease (AD) and behavioral variant frontotemporal dementia (bvFTD). Semantic knowledge can be evaluated through different tests; however, most of them depend on language. OBJECTIVE: We describe the development of a brief drawing task that may be helpful for the differential diagnosis of SD. METHODS: Seventy-two patients, including 32 AD, 19 bvFTD, and 21 SD were asked to draw 12 items with different age of acquisition and familiarity, belonging to four different semantic categories. We employed the drawings of healthy volunteers to build a scoring scheme. RESULTS: Turtle, strawberry, train, and envelope were the items of each category that best discriminated between groups and were selected for the Brief drawing task. The discriminatory power of the Brief drawing task between SD versus AD and bvFTD patients, estimated through the area under the curve was 0.84 (95% CI = 0.72-0.96, p = 0.000007). In a logistic model, the Brief drawing task (p = 0.003) and VOSP "number location" subtest (p = 0.016) were significant predictors of the diagnosis of SD versus AD and bvFTD after adjustment by the main covariates. The Brief drawing task provided clinically useful qualitative information. SD drawings were characterized by loss of the distinctive features, intrusions, tendency to prototype, and answers like "I don't know what this is". CONCLUSION: The Brief drawing task appears to reveal deficits in semantic knowledge among patients with SD that may assist in the differential diagnosis with other neurodegenerative diseases.


Frontotemporal Dementia/diagnosis , Frontotemporal Dementia/psychology , Neuropsychological Tests , Psychomotor Performance/physiology , Recognition, Psychology/physiology , Aged , Aged, 80 and over , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Neuropsychological Tests/standards
6.
Neurobiol Aging ; 64: 58-67, 2018 04.
Article En | MEDLINE | ID: mdl-29331877

The diagnostic value of cerebrospinal fluid (CSF) biomarkers is well established in Alzheimer's disease, but our current knowledge about how abnormal CSF levels affect cerebral integrity, at local and network levels, is incomplete in asymptomatic older adults. Here, we have collected CSF samples and performed structural magnetic resonance imaging scans in cognitively normal elderly as part of a cross-sectional multicenter study (SIGNAL project). To identify group differences in cortical thickness, white matter volume, and properties of structural networks, participants were split into controls (N = 20), positive amyloid-ß (Aß1-42+) (N = 19), and positive phosphorylated tau (N = 18). The Aß1-42+ group exhibited thickening of middle temporal regions, while positive phosphorylated tau individuals showed thinning in the superior parietal and orbitofrontal cortices. Subjects with abnormal CSF biomarkers further showed regional white matter atrophy and more segregated cortical networks, the Aß1-42+ group showing heightened isolation of cingulate and temporal cortices. Collectively, these findings highlight the relevance of combining structural brain imaging and connectomics for in vivo tracking of Alzheimer's disease lesions in asymptomatic stages.


Alzheimer Disease/diagnosis , Alzheimer Disease/pathology , Cerebral Cortex/pathology , Gray Matter/pathology , Nerve Net/pathology , Aged , Amyloid beta-Peptides/cerebrospinal fluid , Atrophy , Biomarkers/cerebrospinal fluid , Cerebral Cortex/diagnostic imaging , Cross-Sectional Studies , Female , Gray Matter/diagnostic imaging , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Peptide Fragments/cerebrospinal fluid , Prodromal Symptoms , Risk , tau Proteins/cerebrospinal fluid
7.
Neurobiol Aging ; 36(6): 2018-23, 2015 Jun.
Article En | MEDLINE | ID: mdl-25865441

Cerebrospinal fluid YKL-40 has been described as a marker of glial inflammation. We aimed to study the relationship between YKL-40 and brain structure and its interactions with core Alzheimer's disease (AD) biomarkers. We measured cortical thickness (CTh) and cerebrospinal fluid biomarkers (amyloid-ß 1-42 [Aß42], total tau, p-tau, and YKL-40) of 80 cognitively normal controls and 27 patients with amnestic mild cognitive impairment. Subjects were classified as Aß42+ (<550 pg/mL) or Aß42- (>550 pg/mL). CTh difference maps were derived from the interaction and correlation analyses in the whole sample and within clinical groups. There was a strong correlation between YKL-40 and markers of neurodegeneration (total tau and p-tau). In the whole sample, we found a negative correlation between YKL-40 and CTh in AD vulnerable areas in Aß42+ subjects but not in Aß42 participants. Our results suggest that YKL-40 could track the inflammatory processes associated to tau-related neurodegeneration in the presence of the AD pathophysiological process.


Adipokines/cerebrospinal fluid , Alzheimer Disease/diagnosis , Cerebral Cortex/pathology , Cognitive Dysfunction/diagnosis , Lectins/cerebrospinal fluid , Aged , Alzheimer Disease/pathology , Atrophy , Biomarkers/cerebrospinal fluid , Chitinase-3-Like Protein 1 , Cognitive Dysfunction/pathology , Female , Humans , Inflammation , Magnetic Resonance Imaging , Male , Middle Aged , tau Proteins/cerebrospinal fluid
8.
Clin Neurophysiol ; 126(4): 810-9, 2015 Apr.
Article En | MEDLINE | ID: mdl-25213352

OBJECTIVE: Although prevailing spinal nerve involvement has been recognized in a few detailed Guillain-Barré syndrome (GBS) autopsy reports, imaging studies addressing this question in cervical nerves are lacking. METHODS: We describe clinical, electrophysiological, ultrasonographic (US) and pathological findings in six consecutive early GBS patients, evaluated within 10 days of onset. RESULTS: Patients' ages ranged from 37 to 80 years. Five patients required mechanical ventilation, two of them having died 9 and 28 days after onset. Upper- and lower-limb nerve US showed abnormal findings in just 8.8% of scanned peripheral nerves. In comparison with 46 aged-matched control subjects, US of the fifth to seventh cervical nerves showed changes in four cases, which consisted of significant nerve enlargement, blurred boundaries of the corresponding ventral rami, or both. Autopsy study in one case demonstrated that pathology, consisting of demyelination and endoneurial inflammatory oedema, mainly involved cervical and lumbar nerves. CONCLUSIONS: In early GBS inflammatory oedema of spinal nerves is a pathogenically relevant feature to understanding the mechanism of ascending paralysis, particularly when conventional electrophysiological studies are normal or not diagnostic. SIGNIFICANCE: Findings advocate the use of cervical nerve US in early GBS.


Guillain-Barre Syndrome/diagnostic imaging , Guillain-Barre Syndrome/physiopathology , Spinal Nerves/diagnostic imaging , Spinal Nerves/physiopathology , Adult , Aged , Aged, 80 and over , Early Diagnosis , Electrophysiological Phenomena/physiology , Female , Humans , Male , Middle Aged , Ultrasonography
...